Regulation of cathepsin D activity by the FTLD protein progranulin
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
and suggest that PGRN and CTSD might function together to regulate lysosomal activities. In support of this hypothesis, granulin motifs are found in cathepsin-like cysteine proteases in plants [11, 16]. These lines of evidence led us to postulate that an interaction between PGRN and CTSD may exist. To test the physical interaction between PGRN and CTSD, FLAG-tagged CTSD was co-transfected with untagged PGRN in HEK293T cells. Cell lysates were immunoprecipitated with anti-FLAG antibodies. PGRN signal is detected in anti-FLAG CTSD immunoprecipitates but not in the controls (Fig. 1a), suggesting a physical interaction between PGRN and CTSD. Since CTSD is known to interact with prosaposin (PSAP) [6, 10], which we previously showed to bind to PGRN as well [17], it is possible that the PGRN and CTSD interaction might be bridged by endogenous PSAP in HEK293T cells. To rule out this possibility, we compared the interaction between PGRN and CTSD in control N2a cells or N2a cells with PSAP expression depleted using the CRISPR/Cas9 system [17]. PSAP ablation has no effect on PGRN-CTSD binding in the coimmunoprecipitation assay (Fig. 1b), indicating that the interaction between PGRN and CTSD is not mediated by PSAP. Co-immunoprecipitation studies between individual granulins and CTSD suggest that multiple granulin motifs interact with CTSD (Supplemental Fig. 2a and 2b). With the physical interaction between PGRN and CTSD confirmed, next, we wanted to investigate its functional relevance. Since CTSD deficiency results in much more severe lysosomal phenotypes than PGRN deficiency [4], we hypothesized that PGRN might regulate CTSD activities. Therefore, we measured CTSD activities in 2-monthold wild type (WT) and PGRN-deficient mice before the appearance of any obvious lysosomal abnormalities or glial activation. Indeed, liver and spleen lysates from Progranulin (PGRN) protein, encoded by the granulin (GRN) gene, has been recently implicated in several neurodegenerative diseases [2, 5]. While haploinsufficiency of PGRN leads to frontotemporal lobar degeneration (FTLD) [2, 5], the most prevalent form of early onset dementia after Alzheimer’s disease (AD), complete loss of PGRN is known to cause neuronal ceroid lipofuscinosis (NCL) [1, 13], a group of lysosomal storage diseases. PGRN is a secreted glycoprotein of 7.5 granulin repeats [2, 5]. However, within the cell, PGRN is localized to lysosomes through two independent trafficking pathways [8, 17]. Furthermore, GRN is transcriptionally co-regulated with a number of essential lysosomal genes by the transcriptional factor TFEB [3]. While all these studies suggest an essential role of PGRN in regulating lysosomal function, how PGRN does so is still unclear. Cathepsin D (CTSD) is a lysosomal aspartic-type protease involved in many neurodegenerative diseases [14]. Mutations in the cathepsin D gene (CTSD) result in NCL in humans [9]. Interestingly, mice deficient in CTSD also develops TDP-43 aggregates (Supplementary Fig. 1) [7], a hallmark of FTLD with GRN mutations. FTLD patients with GRN mutations exhibit typical pathological features of NCL [7]. These data support that lysosomal dysfunction might serve as a common mechanism for FTLD and NCL
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Strikingly Different Clinicopathological Phenotypes Determined by Progranulin-Mutation Dosage
Smith, K. R., Damiano, J., Franceschetti, S., Carpenter, S., Canafoglia, L., Morbin, M., Rossi, G., Pareyson, D., Mole, S. E., Staropoli, J. F., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.04.021 · Cited by 489 · cited 4×
“These data support that lysosomal dysfunction might serve as a common mechanism for FTLD and NCL Electronic supplementary material The online version of this article (doi:10.1007/s00401-017-1719-5) contains supplementary material, which is available to authorized users.”
InfluentialIndividuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis
Ward, M. E., Chen, R., Huang, H.-Y., Ludwig, C., Telpoukhovskaia, M., Taubes, A., Boudin, H., Minami, S. S., Reichert, M., Albrecht, P., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aah5642 · Cited by 193 · cited 1×
“Indeed, a recent study demonstrated reduced cathepsin D activity in fibroblasts derived from FTLD patients with heterozygous GRN mutations [15].”
The Role of Cathepsin D in the Pathogenesis of Human Neurodegenerative Disorders
Vidoni, C., Follo, C., Savino, M., Melone, M. A. B., & Isidoro, C. (2016) · Medicinal Research Reviews · doi:10.1002/med.21394 · Cited by 164 · cited 2×
“Cathepsin D (CTSD) is a lysosomal aspartic-type protease involved in many neurodegenerative diseases [14].”
Almeida, M. R., Macário, M. C., Ramos, L., Baldeiras, I., Ribeiro, M. H., & Santana, I. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.019 · Cited by 125
Cited by
Logan, T., Simon, M. J., Rana, A., Cherf, G. M., Srivastava, A., Davis, S. S., Low, R. L. Y., Chiu, C.-L., Fang, M., Huang, F., et al. (2021) · Cell · doi:10.1016/j.cell.2021.08.002 · Cited by 233
The lysosomal function of progranulin, a guardian against neurodegeneration
Paushter, D. H., Du, H., Feng, T., & Hu, F. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1861-8 · Cited by 230
“CTSD activity was significantly decreased across a range of tissue lysates from Grn−/− mice by as early as 2 months of age [154], and heterozygous GRN mutant iPSC-derived cortical neurons showed a significant decrease in CTSD activity, despite the above-mentioned increase in mature CTSD protein levels [131].”
InfluentialSelf-citationHomozygous GRN mutations: new phenotypes and new insights into pathological and molecular mechanisms
Huin, V., Barbier, M., Bottani, A., Lobrinus, J. A., Clot, F., Lamari, F., Chat, L., Rucheton, B., Fluchère, F., Auvin, S., et al. (2020) · Brain · doi:10.1093/brain/awz377 · Cited by 96
Loss of TMEM106B and PGRN leads to severe lysosomal abnormalities and neurodegeneration in mice
Feng, T., Mai, S., Roscoe, J. M., Sheng, R. R., Ullah, M., Zhang, J., Katz, I. I., Yu, H., Xiong, W., & Hu, F. (2020) · The EMBO Reports · doi:10.15252/embr.202050219 · Cited by 94
“Upon reaching the lysosome, PGRN is processed to granulin peptides by cathep-sins (Holler et al , 2017; Lee et al , 2017; Zhou et al , 2017b).”
InfluentialSelf-citationLysosomal functions of progranulin and implications for treatment of frontotemporal dementia
Simon, M. J., Logan, T., DeVos, S. L., & Di Paolo, G. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.09.006 · Cited by 94
Metadata
- Authors
- Zhou, X., Paushter, D. H., Feng, T., Pardon, C. M., Mendoza, C. S., & Hu, F.
- Venue
- Acta Neuropathologica
- Published
- 2017-05-10
- Volume
- 134
- Issue
- 1
- Pages
- 151-153
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2611980053
- Cited by
- 89
- References
- 4
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Regulation of cathepsin D activity by the FTLD protein progranulin. https://app.cochat.ai/papers/10.1007/s00401-017-1719-5
- The paper
- Zhou, X., Paushter, D. H., Feng, T., Pardon, C. M., Mendoza, C. S., & Hu, F. (2017). Regulation of cathepsin D activity by the FTLD protein progranulin. Acta Neuropathologica. https://doi.org/10.1007/s00401-017-1719-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.